Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Gong, Xiping ^a   Zou, Xinying ^a   Liu, Liping ^a   Pu, Yuehua ^a   Wang, Yilong ^a   Pan, Yuesong ^a   Soo, Yannie O Y ^b   Leung, Thomas W H ^b   Zhao, Xingquan ^a   Wang, Yongjun ^a   Wong, Ka Sing ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN ISCHEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIATOR; MIDDLE CEREBRAL ARTERY OCCLUSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; AGED; BLOOD; CEREBROVASCULAR ACCIDENT; FOLLOW UP; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; REPRODUCIBILITY; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME; CONSTRICTION, PATHOLOGIC; STROKE;

C REACTIVE PROTEIN;

AGED; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CONSTRICTION, PATHOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; STROKE; TREATMENT OUTCOME;

EID: 84884229897     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/850714     Document Type: Article

References (33)

1. Tuttolomondo A., Di Raimondo D., Pecoraro R., Arnao V., Pinto A., Licata G., Atherosclerosis as an inflammatory disease. Current Pharmaceutical Design 2012 18 4266 4288
2. Montero-Vega M. T., The inflammatory process underlying atherosclerosis. Critical Reviews in Immunology 2012 32 373 462
3. Anogeianaki A., Angelucci D., Cianchetti E., D'Alessandro M., Maccauro G., Saggini A., Salini V., Caraffa A., Teté S., Conti F., Tripodi D., Shaik-Dasthagirisaheb Y. B., Atherosclerosis: a classic inflammatory disease. International Journal of Immunopathology and Pharmacology 2011 24 4 817 825 2-s2.0-84856574993
4. Libby P., Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 2045 2051
5. Simard J. M., Kent T. A., Chen M., Tarasov K. V., Gerzanich V., Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurology 2007 6 3 258 268 2-s2.0-33846882646 10.1016/S1474-4422(07)70055-8
6. Jung J. E., Kim G. S., Chen H., Maier C. M., Narasimhan P., Song Y. S., Niizuma K., Katsu M., Okami N., Yoshioka H., Sakata H., Goeders C. E., Chan P. H., Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Molecular Neurobiology 2010 41 2-3 172 179 2-s2.0-77954201785 10.1007/s12035-010-8102-z
7. Stankowski J. N., Gupta R., Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxidants and Redox Signaling 2011 14 10 1841 1851 2-s2.0-79954571076 10.1089/ars.2010.3292
8. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., Wardlaw J., Dennis M., Sudlow C., Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Medicine 2009 6 9 2-s2.0-70349636710 10.1371/journal.pmed.1000145 e1000145
9. Wu T. H., Chien K. L., Lin H. J., Hsu H. C., Su T. C., Chen M. F., Lee Y. T., Total white blood cell count or neutrophil count predict ischemic stroke events among adult Taiwanese: report from a community-based cohort study. BMC Neurology 2013 13, article 7
10. Kazmierski R., Guzik P., Ambrosius W., Ciesielska A., Moskal J., Kozubski W., Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clinical Neurology and Neurosurgery 2004 107 1 38 43 2-s2.0-9344232723 10.1016/j.clineuro.2004.03.003
11. Grau A. J., Boddy A. W., Dukovic D. A., Buggle F., Lichy C., Brandt T., Hacke W., Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004 35 5 1147 1152 2-s2.0-2142716833 10.1161/01.STR.0000124122. 71702.64
12. Zhang W., Sun K., Chen J., Liao Y., Qin Q., Ma A., Wang D., Zhu Z., Wang Y., Hui R., High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clinical Science 2010 118 3 187 194 2-s2.0-70549089810 10.1042/CS20090142
13. Cui R., Moriyama Y., Koike K. A., Date C., Kikuchi S., Tamakoshi A., Iso H., Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis 2008 198 2 412 418 2-s2.0-43949122229 10.1016/j.atherosclerosis.2007.09.029
14. Yan J., Liao J. K., Wang D., Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients. Journal of Huazhong University of Science and Technology 2010 30 643 647
15. Wu X. Q., Ding J., Ge A. Y., Liu F. F., Wang X., Fan W., Acute phase homocysteine related to severity and outcome of atherothrombotic stroke. European Journal of Internal Medicine 2013 24 362 367
16. Den Hertog H. M., Van Rossum J. A., Van Der Worp H. B., Van Gemert H. M. A., De Jonge R., Koudstaal P. J., Dippel D. W. J., C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. Journal of Neurology 2009 256 12 2003 2008 2-s2.0-71849109771 10.1007/s00415-009-5228-x
17. Shantikumar S., Grant P. J., Catto A. J., Bamford J. M., Carter A. M., Elevated C-reactive protein and long-term mortality after ischaemic stroke relationship with markers of endothelial cell and platelet activation. Stroke 2009 40 3 977 979 2-s2.0-62449089772 10.1161/STROKEAHA.108.525105
18. Di Napoli M., Papa F., Bocola V., C-reactive protein in ischemic stroke an independent prognostic factor. Stroke 2001 32 4 917 924 2-s2.0-0035067998
19. Samuels O. B., Joseph G. J., Lynn M. J., Smith H. A., Chimowitz M. I., A standardized method for measuring intracranial arterial stenosis. American Journal of Neuroradiology 2000 21 4 643 646 2-s2.0-0034128435
20. Akins P. T., Pilgram T. K., Cross D. T. 3rd, Moran C. J., Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998 29 2 433 438 2-s2.0-0031885164
21. Mannini L., Marcucci R., Paniccia R., Antonucci E., Giglioli C., Valente S., Gori A. M., Prisco D., Gensini G. F., Abbate R., Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients. Clinical Hemorheology and Microcirculation 2006 35 1-2 175 181 2-s2.0-33746444276
22. Grad E., Golomb M., Koroukhov N., Lawson J. A., Lotan C., Fitzgerald G. A., Danenberg H. D., Aspirin reduces the prothrombotic activity of C-reactive protein. Journal of Thrombosis and Haemostasis 2009 7 8 1393 1400 2-s2.0-67949083606 10.1111/j.1538-7836.2009.03511.x
23. McCarthy M. W., Kockler D., Feliú J. F., Kaiser J., Clopidogrel-associated leukopenia. Annals of Pharmacotherapy 2003 37 2 216 219 2-s2.0-0037317138
24. Albert M. A., Danielson E., Rifai N., Ridker P. M., Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. Journal of the American Medical Association 2001 286 1 64 70 2-s2.0-0035806626
25. Lonn E., Yusuf S., Arnold M. J., Sheridan P., Pogue J., Micks M., McQueen M. J., Probstfield J., Fodor G., Held C., Genest J. Jr., Homocysteine lowering with folic acid and B vitamins in vascular disease. The New England Journal of Medicine 2006 354 15 1567 1577 2-s2.0-33645753544 10.1056/NEJMoa060900
26. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M. B., Thompson S. G., Collins R., Danesh J., C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet 2010 375 132 140
27. Winbeck K., Poppert H., Etgen T., Conrad B., Sander D., Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002 33 10 2459 2464 2-s2.0-0036792815 10.1161/01.STR.0000029828. 51413.82
28. Bønaa K. H., Njølstad I., Ueland P. M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J. E., Arnesen E., Rasmussen K., Homocysteine lowering and cardiovascular events after acute myocardial infarction. The New England Journal of Medicine 2006 354 15 1578 1588 2-s2.0-33645796222 10.1056/NEJMoa055227
29. Ebbing M., Bleie Ø., Ueland P. M., Nordrehaug J. E., Nilsen D. W., Vollset S. E., Refsum H., Ringdal Pedersen E. K., Nygård O., Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. Journal of the American Medical Association 2008 300 7 795 804 2-s2.0-49949101867 10.1001/jama.300.7.795
30. Jakubowski J. A., Thompson C. B., Vaillancourt R., Arachidonic acid metabolism by platelets of differing size. British Journal of Haematology 1983 53 3 503 511 2-s2.0-0020692967
31. Arevalo-Lorido J. C., Carretero-Gomez J., Alvarez-Oliva A., Gutierrez-Montano C., Fernandez-Recio J. M., Najarro-Diez F., Mean platelet volume in acute phase of ischemic stroke, as predictor of mortality and functional outcome after 1 year. Journal of Stroke and Cerebrovascular Diseases 2013 22 4 297 303 10.1016/j.jstrokecerebrovasdis.2011.09.009
32. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., Lalouschek W., Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004 35 7 1688 1691 2-s2.0-3042641726 10.1161/01.STR.0000130512.81212.a2
33. Youssef M. Y. Z., Mojiminiyi O. A., Abdella N. A., Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Translational Research 2007 150 3 158 163 2-s2.0-34548137030 10.1016/j.trsl.2007.02.006